Votre navigateur ne supporte pas le javascript Wallonia & Brussels against COVID-19 - See all

See all

Justine Gaugue, Professor, Laurence Ris, Professor - Mandy Rossignol, Professor

UMONS
" The UMONS Health Research Institute, on the initiative of Justine Gaugue, Laurence Ris and Mandy Rossignol, in collaboration with the MUMONS, have set up a user-friendly and pleasant website (www.home-stress-home.com) for children and young people, containing information, resources and a link to an online survey to assess anxiety levels. The data will be collected for research purposes to better understand the development of anxiety disorders in often neglected populations: the children and the young adults in school or early working life. This interface, based on the results of the survey, will make it possible to provide personalized feedback to the user, in order to direct him/her towards relaxation strategies or specialists if the level of anxiety measured is very high. Other surveys and tools will be added later on to allow longitudinal monitoring of the impact on mental and physical health of the stress generated by the current crisis. The objective is to develop this...

Karim Amighi, Professor

ULB
" Inhaled ivermectin against COVID-19 study. Development of solution for nebulisation - preclinical safety and efficacy in animal models and clinical evaluation. CORONAVIRUS 2020 (CUR) research project submitted to FNRS on May 1, 2020. "
Funding: FNRS (requested)
Contact: Professor Karim Amighi Laboratory of Pharmaceutics and biopharmaceutics Université libre de Bruxelles (ULB) Faculty of Pharmacy Campus Plaine, CP-207 Boulevard du Triomphe, B-1050 Brussels - Belgium This email address is being protected from spambots. You need JavaScript enabled to view it.

Keith Durkin, Dr - Maria Artesi, Dr - Sébastien Bontems, Dr - Marie-Pierre Hayette, Dr- Vincent Bours, Dr

ULiège
" Since SARS-CoV-2 testing began at the CHU of Liège we have been carrying out regular whole genome sequencing (WGS) of COVID-19 samples. At the time of writing we have uploaded 187 viral genomes to https://nextstrain.org/ (almost half of the 393 from Belgium). We have carried out regular WGS to monitor the evolution of viral haplotypes. Where possible we have concentrated on health care workers with the goal of identifying clusters of transmission. This included a cluster of seven individuals who were tested on the Roche cobas® instrument using the SARS-CoV-2 test, all were positive for the ORF1ab assay, but negative for the second E-gene assay. To date we have WGS data from four of these individuals, all share identical viral genomes and a SNP in the E-gene has been identified as the most probable cause of the test failure. This observation highlights the importance of redundancy in SARS-CoV-2 assays, especially as some testing regimes recommend an E-gene assay as a primary...

Khanh TRAN DUY

3D-Side S.A.
" "- 3D printing of swabs in SLS - 3D printing of valves - 3D printing of connectors for respiratory systems - Advice on guidelines on the manufacturing and post processing of such devices." "
Contact: Khanh TRAN DUY This email address is being protected from spambots. You need JavaScript enabled to view it.

Kyun Thibaut, Founder and Managing Director

Covartim
"In the global effort to help the healthcare professionals in the fight against the Covid pandemic, we are providing documents to help manufacturers that are not familiar with medical devices to properly document their work to help them in their product development and achieving compliance. These templates are derived from our technical file documentation and include some reference to guidances (mostly applicable in Belgium) for devices and accessories to answer to hospital products shortage."
Contact : Covartim www.covartim.be This email address is being protected from spambots. You need JavaScript enabled to view it.

Laure Elens, Professor

UCLouvain
" I have been asked by the IATDMCT to pilot a review sumarizing the potential interactions that it could have between investigational COVID antivirals and immunosuppressants (used to avoid rejection in solid organ transplantation) "
Publication References: PubMed ID=32304488 Pharmacologic treatment of transplant recipients infected with SARS-CoV-2: considerations regarding therapeutic drug monitoring and drug-drug interactions. Ther Drug Monit. 2020 Apr 15. doi: 10.1097/FTD.0000000000000761. [Epub ahead of print]
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

Laurence Delacroix, Dr. - Marielle Lebrun, Dr. - Catherine Sadzot, Pr.

ULiège, GIGA-Research
" Development of specific antigens to allow the detection of circulating antibodies against SARS-CoV-2. Our aim is to contribute to the development of serological tests that could help identifying the people previously infected by SARS-CoV-2 and detect the presence of neutralizing antibodies, which would predict an individual protection against COVID-19. With the help of local renowned companies, we are currently testing various antigens and optimizing their production. "
Contact: Dr. Laurence Delacroix (This email address is being protected from spambots. You need JavaScript enabled to view it.), Neurodevelopmental Biology, GIGA-Neurosciences and GIGA-Stem Cells, 15 avenue Hippocrate, CHU-B36, B-4000 Liège). Dr. Marielle Lebrun (This email address is being protected from spambots. You need JavaScript enabled to view it.) and Pr. Catherine Sadzot (This email address is being protected from spambots. You need JavaScript enabled to view it.), laboratory of Immunology and Virology, GIGA-I3, 11 Avenue de l'hôpital, 4000 Liège.

Laurent Gillet, Professor - Fabrice Bureau, Professor

ULiège
" The first objectives of our approach was to strongly increase the testing capacity for virus by using protocols that are as effective as possible and above all not very dependent on the external sources of consumables and reagents whose supply is threatened. The ULiege testing platform can analyse more than 3000 samples per day and is member on the National testing platform. "
Contact: Prof Fabrice BUREAU Vice-Recteur à la Recherche, Université de Liège Place du 20-Août, 7 B-4000, Liège Belgique Tél: +32 4 366 32 14 Prof Laurent GILLET Université de Liège Quartier Vallée, 2 Avenue de Cureghem, 10 B-4000, Liège Belgique Tél: +32 4 366 42 86

Louise-Amélie Cougnon, Dr. UCLouvain - Louis de Viron, CEO Datatext

UCLouvain, Datatext
“The project aims at measuring the impact of the Covid-19 crisis on the French-speaking Belgium population through the analysis of discourses on social media. In particular, we work on an open corpus of (today) 4.000 tweets from politicians, 30.000 from the media and 100.000 from the population. All messages include a Covid-19 related expression. We focus on three main research topics: (1) the diachronic evolution of discourses, from the emergence of the disease in China to reopening plans, through lockdown measures; (2) the impact of political discourse on the acceptance of measures by citizens and (3) the role of the language used by the media in measures’ acceptance and anxiety of the population.”
Funding: Seeking funding 
Contact: Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.  Website: https://uclouvain.be/instituts-recherche/ilc/miil/reseaux-sociaux.html 

Luc Willems, FNRS Research Director

ULiège - FNRS - Royal Academy of Medicine of Belgium
" Massive infiltration of activated macrophages is associated with the development of a cytokine storm that leads to severe acute respiratory syndrome induced by SARS-CoV-2. Based on our results demonstrating the key role exerted by epigenetic regulation in the activity of macrophages, we propose to study the methyltransferase EZH2 in the pathogenesis induced by SARS-CoV-2. We have also shown that the PD-1 immune checkpoint is responsible for the macrophage anergy induced by the absence of EZH2. The goal of the project is to temper the excessive inflammatory responses associated with macrophages by interfering on the EZH2-PD-1 axis. "
Funding: Decision pending (FNRS Crédit Urgent de Recherche 40002642)
Publication References: - Inhibition of EZH2 methyltransferase decreases immunoediting of mesothelioma cells by autologous macrophages through a PD-1-dependent mechanism. Malik Hamaidia, Hélène Gazon, Clotilde Hoyos, Gabriela...

M. Piagnerelli, Professor, CHU-Charleroi-ULB - K. Zouaoui Boudjeltia, Professor, CHU-Charleroi-ULB - D. Touboul, Research fellow CNRS ICSN UPR2301 (France) -v F. Souard, Professor, ULB - C. Delporte, Professor ULB - P. Van Antwerpen, Professor ULB

ULB and CHU-Charleroi
" MAker Study for COVID-19 Patient follow-up in intensive Care Unit (MASC-19) Around 5-10 % of patients suffering from COVID-19 symptom aggravation require intensive care. Among them half will die. COVID-19 is often compared to sepsis however few are known about this pathology and physicians are unable to discriminate which patients will suffer from severe symptoms. For this reason, Mask-19 project, which gathers CHU-Charleroi, the Faculties of Medicine and Pharmacy (ULB) and CNRS (France), will investigate markers in sera of COVID-19 patients collected in March and April 2020. They will be compared to septic patients by metabolomics and molecular networks for a better follow up of this specific patients "
Funding: COVID-ULB
Contact: Prof. Dr Pierre Van Antwerpen Dean of the Faculty of Pharmacy RD3- Pharmacognosy, Bioanalysis, Drug Discovery and Analytical Platform of the Faculty of Pharmacy This email address is being protected from spambots. You need JavaScript enabled to view it. +3226505263 +3226505249...

Marc Haelterman, Professor

ULB
" CliPeDia is a website that makes science and mathematics lessons available free of charge to secondary school students. The project is led by Marc Haelterman, professor at the Brussels Polytechnic (ULB) as part of research in techno-pedagogy. Upon the announcement of the confinement, a communication campaign (Facebook and radio and TV press) was launched to invite students and their teachers to use CliPeDia as a course medium in the implementation of their distance courses. The result of this campaign has been remarkable in that, since the beginning of the containment measures, CliPeDia's audience has doubled. In just a few days, it actually went from 5,000 to more than 10,000 views per day. In the difficult learning conditions imposed by confinement, CliPeDia thus appears as a useful teaching tool for high school students and their teachers. "
Contact: Prof. Marc Haelterman Ecole polytechnique de Bruxelles, ULB Service OPERA-Photonique, CP 194/5 tél. 02 650 28 21 e-mail...

Marcus Dejardin, Professor - Frank Janssen, Professor

UCLouvain, UNamur
" The measures that governments have taken in response to the current COVID-19 outbreak differ substantially across countries. On the initiative of the Erasmus University Rotterdam, researchers of twelve universities worldwide have been working together to study the response to these measures. Data has been collected of the self-reported behaviour and perception of students related to the COVID-19 measures. How important do they think the Covid-19 measures are, how serious do they take the measures, and to which degree do they follow or violate them? Furthermore, the relationship with perceived risk of COVID-19 and several personality traits will be studied. The success of the approach of governments is entirely dependent on the compliance of the population with the prescribed measures. Therefore, gaining insight in the determinants of compliance is important. The study will improve our understanding of behaviour in times of crisis and advance the development of...

Marianne Rooman, FNRS Research Director - Fabrizio Pucci, FNRS Postdoctoral Researcher

ULB - FNRS
" Computational analysis of the impact of SARS-CoV-2 on the renin-angiotensin system. "
Funding: FNRS
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it. This email address is being protected from spambots. You need JavaScript enabled to view it.

Contact us

c/o F.R.S. - FNRS

Rue d’Egmont 5

B - 1000 Bruxelles

Tél : +32 2 504 92 11

info@COVID19-WB.be

Brussels & Wallonia against COVID19